Optimization of the acquisition costs for secondary packaging in the pharmaceutical industry with the emphasis on the choise of materials and new technologies

Farmacevtska industrija sodi med najpomembnejše in najzahtevnejše panoge na svetu. Proizvodnja zdravil in embalaža v farmacevtski industriji sta z vidika stroškov ključnega pomena. Pod nenehnim nadzorom raznih inšpekcij mora upoštevati predpisane standarde, ki veljajo tako za zdravilne učinkovine kot embalažo. V podjetju Krka, d. d., se srečujemo s pakiranjem različnih zdravilnih oblik v različno ovojnino. Vsaka ovojnina ima specifične lastnosti in zahteve. Izbiramo jo v oddelku za razvoj embalaže v sodelovanju z marketingom. Preden pa se odločimo za nabavo večjih količin, jo preizkusimo v pilotni proizvodnji, kjer se pokažejo določene pomanjkljivosti in prednosti. S trenutnim dobaviteljem A sodelujemo že skoraj 20 let. S sodobno tehnologijo tiska pa lahko spremenimo dizajn embalaže in posledično znižamo stroške.The pharmaceutical industry is one of the most important and demanding industries in the world. Production and packaging of medicines in the pharmaceutical industry are key points in terms of cost. Regulatory standards for packaging and active substances must be respected. We are facing various different forms of medicaments in different packaging. Each pack has specific characteristics and requirements. It is chosen in collaboration with marketing and packaging development department. Before we decide to purchase large quantities, it is tested in pilot production, which shows weak and strong points of its use. We have been collaborating for almost 20 years with the current supplier A. With modern technology in print design it is possible to change packaging and consequently reduce costs